Stomach Neoplasms
Information
- Disease name
- Stomach Neoplasms
- Disease ID
- Description
Disease area statistics
Chromosome band
| Gene symbol | Chromosome | Start | Stop | The number of variant |
|---|---|---|---|---|
| TP53 | 17 | 7,668,421 | 7,687,490 | 34 |
| ARID1A | 1 | 26,696,015 | 26,782,104 | 14 |
| KMT2D | 12 | 49,018,978 | 49,060,794 | 10 |
| RAD50 | 5 | 132,556,977 | 132,646,349 | 8 |
| PTPRD | 9 | 8,314,246 | 10,613,002 | 8 |
| CDH1 | 16 | 68,737,292 | 68,835,537 | 8 |
| KMT2B | 19 | 35,718,003 | 35,738,878 | 8 |
| KMT2C | 7 | 152,134,925 | 152,436,003 | 6 |
| KMT2A | 11 | 118,436,492 | 118,526,832 | 6 |
| NUP93 | 16 | 56,730,129 | 56,850,286 | 6 |
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03979131 | Active, not recruiting | Phase 2 | Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC) | August 22, 2019 | June 15, 2026 |
| NCT04660929 | Active, not recruiting | Phase 1 | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | February 2, 2021 | December 31, 2024 |
| NCT05602935 | Active, not recruiting | Phase 2 | Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study | September 16, 2020 | December 30, 2026 |
| NCT06260150 | Active, not recruiting | N/A | Application of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients. | April 1, 2023 | April 2024 |
| NCT05334719 | Active, not recruiting | A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric Cancer | February 3, 2022 | September 30, 2026 | |
| NCT03675737 | Active, not recruiting | Phase 3 | Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859) | November 8, 2018 | March 1, 2025 |
| NCT04574245 | Active, not recruiting | Gastric Cancer Liver Metastasis Cohort of China | January 1, 2010 | December 31, 2022 | |
| NCT01133951 | Active, not recruiting | N/A | Helicobacter Pylori Eradication to Prevent Gastric Cancer | June 2010 | May 2032 |
| NCT05795296 | Active, not recruiting | Phase 2 | Efficacy and Safety of Fruquintinib With Sintilimab as First-line Therapy in Gastric Cancer | December 1, 2022 | August 31, 2025 |
| NCT05001321 | Active, not recruiting | Multi-center and Multi-modal Deep Learning Study of Gastric Cancer | July 1, 2021 | December 31, 2024 | |
| NCT02485015 | Active, not recruiting | Phase 2 | The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer | June 2015 | June 2033 |
| NCT02338518 | Active, not recruiting | Phase 3 | Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients | January 4, 2015 | October 2023 |
| NCT00343239 | Completed | Phase 2 | Docetaxel in Locally Advanced Gastric Adenocarcinoma | June 2006 | March 2012 |
| NCT00374985 | Completed | Phase 1/Phase 2 | Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction | October 2005 | September 2013 |
| NCT00375999 | Completed | Phase 2 | Docetaxel and Epirubicin in Advanced Gastric Cancer | September 2006 | December 2006 |
| NCT00382720 | Completed | Phase 2 | Docetaxel and Oxaliplatin in Gastric Cancer | September 2006 | April 2010 |
| NCT00390416 | Completed | Phase 2 | Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma | October 2006 | January 2012 |
| NCT00411229 | Completed | Phase 3 | Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer | June 2006 | November 2012 |
| NCT00447330 | Completed | Phase 2 | Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma | February 2007 | July 2014 |
| NCT00511446 | Completed | Phase 2 | Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer | August 2007 | January 2013 |
| NCT00512681 | Completed | Phase 2 | A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer | July 2007 | July 2009 |
| NCT00515216 | Completed | Phase 2 | Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors | August 2007 | November 2013 |
| NCT00525005 | Completed | Phase 2 | Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer | August 2007 | June 2010 |
| NCT00539877 | Completed | Phase 1 | Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal Seeding | October 2004 | August 2007 |
| NCT00553696 | Completed | Phase 1 | Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer | November 2007 | March 2014 |
| NCT00555620 | Completed | Phase 1 | Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer | May 2008 | December 2011 |
| NCT00555672 | Completed | Phase 1 | Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer | August 2008 | August 2010 |
| NCT00568438 | Completed | Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample | October 2000 | December 31, 2015 | |
| NCT05280665 | Completed | Specialization in Gastric Cancer Surgery | February 14, 2022 | March 1, 2023 | |
| NCT00611507 | Completed | Phase 2 | A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer | November 2002 | April 2004 |
| NCT04985084 | Completed | N/A | Development and Testing of a Social Cognitive Theory-based Dietary Behavioral Intervention in Gastric Cancer Survivors | January 12, 2022 | August 15, 2022 |
| NCT00811447 | Completed | Phase 3 | Taxotere New Indication - Gastric Cancer Treatment Registration Trial | November 2008 | June 2012 |
| NCT00813072 | Completed | Phase 2 | Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma | November 2007 | December 2010 |
| NCT00842244 | Completed | Phase 1 | Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer | April 2009 | October 2012 |
| NCT00851305 | Completed | N/A | Detection of Early Gastric Cancers Using Confocal Laser Endomicroscopy | August 2008 | July 2009 |
| NCT00909402 | Completed | Phase 1 | A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas | November 2009 | November 2012 |
| NCT00980382 | Completed | Phase 1/Phase 2 | A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric Carcinoma | September 2004 | August 2007 |
| NCT00983801 | Completed | Phase 2 | Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric Cancer | November 2009 | June 2011 |
| NCT04953585 | Completed | Effectiveness of Managing Suspected Metastasis and Progress Using Plasma D-dimer Testing in Gastric Cancer Patients | January 1, 2019 | January 1, 2021 | |
| NCT01234324 | Completed | Phase 2 | ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction | October 2010 | August 2017 |
| NCT01364376 | Completed | N/A | S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemotherapy for Advanced Gastric Carcinoma | June 2011 | August 2016 |
| NCT01384253 | Completed | Phase 1 | Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy | July 2011 | July 2016 |
| NCT01421680 | Completed | N/A | The Effects of Preoperative and Postoperative Oral Nutritional Supplements in Malnourished Post-gastrectomy Patients | August 2011 | December 2013 |
| NCT01499576 | Completed | N/A | Acetic Acid Chromoendoscopy to Judge Gastric Intestinal Metaplasia | November 2011 | April 2012 |
| NCT01508520 | Completed | a Prospective Study on the Efficacy of Magnifying Endoscopy With Narrow-band Imaging in Diagnosing Gastric Lesions | December 2009 | December 2011 | |
| NCT01531452 | Completed | Phase 2 | The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer | June 2011 | June 2013 |
| NCT01576380 | Completed | Phase 2 | A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients | June 2012 | September 2013 |
| NCT04694183 | Completed | Phase 2 | The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer | August 17, 2020 | May 6, 2023 |
| NCT01614522 | Completed | Phase 2 | A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2 | March 2012 | March 2013 |
| NCT01617876 | Completed | Enhanced Magnifying Endoscopy for Diagnosis of Early Gastric Cancer | March 2010 | March 2012 | |
| NCT01649271 | Completed | Phase 1 | Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer. | July 23, 2012 | June 23, 2016 |
| NCT01653171 | Completed | Phase 4 | Premedication With Simethicone or Simethicone Plus N-acetylcysteine in Improving Visibility During Upper Endoscopy | July 2012 | November 2013 |
| NCT01653496 | Completed | Phase 2 | Compliance to ERAS After Gastric Surgery | July 2012 | February 2014 |
| NCT02658214 | Completed | Phase 1 | Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors | April 28, 2016 | November 14, 2019 |
| NCT02730533 | Completed | N/A | The Efficacy of Esomeprazole Premedication on Intraoperative Bleeding During Gastric ESD | March 2016 | April 2017 |
| NCT00036400 | Completed | Phase 3 | Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by Surgery | December 2001 | December 2003 |
| NCT00041808 | Completed | Phase 1/Phase 2 | Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver | July 2001 | April 2003 |
| NCT00042510 | Completed | Phase 2 | Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer | August 2000 | July 2004 |
| NCT00054873 | Completed | Phase 2 | Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer | November 2003 | December 2004 |
| NCT00087503 | Completed | Phase 2 | Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy | April 2004 | June 2005 |
| NCT00188266 | Completed | Phase 1/Phase 2 | Study of Adjuvant Radiochemotherapy for Gastric Cancer | August 2002 | August 18, 2017 |
| NCT00226811 | Completed | Phase 2 | An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy | January 2006 | May 2008 |
| NCT00263354 | Completed | Phase 2 | Oxaliplatin in Gastric Cancer | October 2003 | July 2006 |
| NCT00001332 | Completed | Phase 1 | Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis | December 1992 | October 2000 |
| NCT06393153 | Completed | Model for Prognosis of Elderly Gastric Cancer Patients | January 1, 2024 | April 20, 2024 | |
| NCT02430636 | Completed | N/A | Irreversible Electroporation(IRE) For Unresectable Stomach Neoplasms | January 1, 2015 | February 1, 2021 |
| NCT03050879 | Completed | Phase 2 | Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection | October 15, 2017 | July 13, 2019 |
| NCT02561494 | Completed | N/A | Postoperative Analgesic Effect of Nefopam | June 2015 | August 2016 |
| NCT02944539 | Completed | Association Between Mitochondrial DNA Content and Risk of Gastric Cancer | March 2016 | September 2016 | |
| NCT02902575 | Completed | N/A | The Safety and Feasibility of Laparoscopic-assisted Gastrectomy for Advanced Gastric Cancer After Neoadjuvant Chemotherapy | September 1, 2016 | November 30, 2019 |
| NCT02649348 | Completed | N/A | Effects of Prehabilitation in Gastric Cancer Patients With Metabolic Syndrome on Perioperative Outcome | September 2015 | February 2018 |
| NCT02650661 | Completed | N/A | Efficacy of a Smart Management Strategy for Health (SMASH) Program for Overcoming Cancer Crisis and Growing Positively | November 23, 2015 | January 2018 |
| NCT02845479 | Completed | Phase 3 | The Thoracic Peri-Operative Integrative Surgical Care Evaluation (POISE) Trial- Stage I | December 7, 2018 | December 7, 2020 |
| NCT01822210 | Completed | Phase 2 | Botulinum Toxin for Stomach Cancer Treatment | January 2013 | May 2016 |
| NCT04539769 | Completed | Phase 2 | Impact of the Type of Reconstruction Methods on Diabetes Following Laparoscopic Distal Gastrectomy in Patients With Gastric Cancer and Type 2 Diabetes | September 1, 2017 | December 31, 2019 |
| NCT01928290 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer | November 8, 2013 | October 28, 2019 |
| NCT01943253 | Completed | N/A | Water-jet Assisted ESD vs Conventional ESD Technique for Treating Early Gastric Cancer | May 2011 | October 2012 |
| NCT00001805 | Completed | Phase 2 | A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab | March 1999 | June 2000 |
| NCT02004769 | Completed | Phase 2 | Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer | November 2013 | June 2016 |
| NCT04439812 | Completed | Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer | January 1, 2010 | December 31, 2018 | |
| NCT02050659 | Completed | Omentectomy in Radical Gastrectomy for Gastric Cancer Trial | March 2012 | February 2014 | |
| NCT04360577 | Completed | N/A | Acupuncture for QoL and Symptoms in Gastric Cancer During Adjuvant Chemotherapy | May 27, 2020 | May 9, 2023 |
| NCT02096666 | Completed | Phase 1/Phase 2 | A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects | April 15, 2014 | December 7, 2018 |
| NCT04107623 | Completed | N/A | Quantitative Fluorescent Guided Robotic Surgery for Cancer of the Gastroesophageal Junction | June 16, 2020 | October 13, 2021 |
| NCT04002128 | Completed | N/A | Tracheal Colonization and Outcome After Major Abdominal Cancer Surgery | January 2008 | March 2012 |
| NCT02200315 | Completed | Phase 2 | No Antimicrobial Prophylaxis for Laparoscopic Distal Gastrectomy | May 2014 | September 2015 |
| NCT03753399 | Completed | N/A | Effect of Acupuncture for QoL in Gastric Cancer Patients Undergoing Adjuvant Chemotherapy: a Pilot Study | January 4, 2019 | April 27, 2020 |
| NCT03524287 | Completed | N/A | Robotic Total Gastrectomy for Locally Advanced Proximal Gastric Cancer | March 1, 2018 | March 10, 2020 |
| NCT03425773 | Completed | Phase 1 | Safety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Receptor 2) Positive Gastric Cancer After Failure to Standard Care | February 26, 2018 | May 13, 2019 |
| NCT02298010 | Completed | Lymph Node Metastasis in Extended Lymphadenectomy for Gastric Cancer From a CLASSIC Trial | January 2016 | December 2017 | |
| NCT02299648 | Completed | N/A | The Screening Protocol for The VIKTORY Trial | July 25, 2014 | May 17, 2022 |
| NCT02301481 | Completed | Phase 2 | A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma | January 2014 | December 2017 |
| NCT02305043 | Completed | Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer | March 2014 | January 31, 2018 | |
| NCT03380052 | Completed | OLGA and OLGIM Stage System for Gastric Cancer | February 2006 | January 2022 | |
| NCT03170180 | Completed | Phase 2 | Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer | March 1, 2017 | December 28, 2021 |
| NCT02327481 | Completed | N/A | Randomized Controlled Trials Comparing Clinical Outcomes of 3D Versus 2D Laparoscopic Surgery for Gastric Cancer | January 1, 2015 | April 26, 2021 |
| NCT03052478 | Completed | Phase 2 | Study of Vismodegib in Advanced Gastric Adenocarcinoma Patients With SMO Overexpression | February 10, 2017 | September 10, 2020 |
| NCT02359058 | Completed | Phase 1 | A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer | February 2015 | November 2016 |
| NCT02370849 | Completed | Phase 2 | Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma | October 2009 | February 2015 |
| NCT02381249 | Completed | N/A | The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery | March 2015 | March 2018 |
| NCT02385617 | Completed | N/A | Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer | January 2014 | December 2017 |
| NCT02385630 | Completed | N/A | Longitudinal Assessment of Gut Hormone Secretion Following Upper Gastrointestinal Surgery for Cancer | March 2015 | July 2018 |
| NCT02406170 | Completed | Phase 1/Phase 2 | Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma | April 2015 | October 2019 |
| NCT03006263 | Enrolling by invitation | N/A | Randomized Controlled Trials on Clinical Outcomes of Totally Laparoscopic Versus Laparoscopy Assisted Total Gastrectomy for Gastric Cancer | November 1, 2016 | November 2024 |
| NCT05819099 | Not yet recruiting | The Role of Artificial Intelligence in Endoscopic Diagnosis of Esophagogastric Junctional Adenocarcinoma：A Single Center, Case-control, Diagnostic Study | December 2023 | April 2026 | |
| NCT05095467 | Not yet recruiting | Phase 2 | HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction | October 2021 | October 2026 |
| NCT05625737 | Not yet recruiting | Phase 2 | Fruquintinib Combined With Sintilimab as Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma | November 2022 | September 2025 |
| NCT05890339 | Not yet recruiting | N/A | Laparoscopic Proximal Gastrectomy With Double-flap Technique Versus Laparoscopic Total Gastrectomy With Roux-en-Y Reconstruction for Proximal Early Gastric Cancer | June 10, 2023 | May 10, 2033 |
| NCT05892289 | Not yet recruiting | N/A | Feasibility and Safety of Robotic Assisted Proximal Gastrectomy With Double-flap Technique for Proximal Early Gastric Cancer | June 10, 2023 | December 10, 2026 |
| NCT04949737 | Not yet recruiting | Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies | April 2024 | December 2026 | |
| NCT04511559 | Not yet recruiting | Methylation Analysis of Circulating Tumor DNA in Gastric Cancer | October 1, 2020 | May 1, 2025 | |
| NCT06451211 | Recruiting | Phase 2 | Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer | May 17, 2023 | November 2027 |
| NCT01950572 | Recruiting | Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma | September 9, 2013 | ||
| NCT02869477 | Recruiting | Institut Paoli Calmettes Cardia Cancer Database | January 2002 | December 2030 | |
| NCT03027427 | Recruiting | Prospective Evaluation and Molecular Profiling in People With Gastric Tumors | February 1, 2017 | December 31, 2030 | |
| NCT03030404 | Recruiting | Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer | January 27, 2017 | December 31, 2030 | |
| NCT03917173 | Recruiting | N/A | Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Gastric Carcinoma.GOETH Study | June 1, 2020 | June 1, 2025 |
| NCT04222114 | Recruiting | Phase 3 | Comparing the Efficacy and Safety of Intra-peritoneal Infusion of Catumaxomab and Treatment of Investigator Choice in Patients With Advanced Gastric Carcinoma With Peritoneal Metastasis | October 6, 2020 | August 31, 2023 |
| NCT04389632 | Recruiting | Phase 1 | A Study of SGN-B6A in Advanced Solid Tumors | June 8, 2020 | October 31, 2028 |
| NCT04393584 | Recruiting | Phase 2/Phase 3 | FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma | January 29, 2019 | January 1, 2026 |
| NCT04710758 | Recruiting | N/A | Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer | January 20, 2021 | December 31, 2025 |
| NCT04943653 | Recruiting | Phase 1/Phase 2 | Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis | June 8, 2021 | December 2025 |
| NCT04949282 | Recruiting | Spanish Series of Patients Treated With the Radionuclide Lutetium177 | May 10, 2021 | December 31, 2035 | |
| NCT05007106 | Recruiting | Phase 2 | MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) | September 16, 2021 | February 22, 2027 |
| NCT05033392 | Recruiting | Phase 2 | PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer | September 14, 2021 | September 30, 2024 |
| NCT05161572 | Recruiting | Phase 2 | Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer | September 28, 2021 | September 30, 2026 |
| NCT05172310 | Recruiting | Phase 1 | PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI | June 2, 2021 | March 31, 2029 |
| NCT05205187 | Recruiting | Gut Microbiota and Metabonomics | February 28, 2022 | December 31, 2025 | |
| NCT05238584 | Recruiting | N/A | Total Versus Partial Omentectomy in the Treatment of Gastric Cancer | January 1, 2022 | July 1, 2024 |
| NCT05352802 | Recruiting | N/A | Multimodal Prehabilitation To Improve The Clinical Outcomes Of Frail Elderly Patients With Gastric Cancer | May 1, 2022 | May 1, 2026 |
| NCT05785234 | Recruiting | N/A | The Effects of Sufentanil vs. Remifentanil in Total Intravenous Anesthesia With Remimazolam on Postoperative Pain | April 2023 | June 2025 |
| NCT05944237 | Recruiting | Phase 1/Phase 2 | HTL0039732 in Participants With Advanced Solid Tumours | July 13, 2023 | September 2026 |
| NCT06047158 | Recruiting | Effects of Omega-3 Fish Oil Fat Emulsion on Rehabilitation and Immune Function After Radical Surgery Combined With Intraperitoneal Hyperthermic Infusion Chemotherapy in Patients With Locally Advanced Gastric Cancer | December 1, 2022 | December 1, 2023 | |
| NCT06131840 | Recruiting | Phase 1 | A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors | November 20, 2023 | March 31, 2030 |
| NCT06157892 | Recruiting | Phase 1/Phase 2 | A Study of Disitamab Vedotin Alone or With Other Anticancer Drugs in Solid Tumors | May 20, 2024 | January 31, 2030 |
| NCT02686424 | Suspended | Tumor Markers Study in Gastric Cancer for Cancer Immunotherapy (ONCO-RD 010 CRT) | March 2010 | ||
| NCT01967875 | Terminated | Phase 2 | A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer | July 2013 | May 2016 |
| NCT05229900 | Terminated | Phase 1 | A Study of SGN-ALPV in Advanced Solid Tumors | April 21, 2022 | December 13, 2023 |
| NCT03061708 | Terminated | Phase 2 | Trial of Single Agent AZD2014 in RICTOR Amplified GC Patients as Second-line Therapy | February 1, 2017 | November 16, 2018 |
| NCT04933227 | Terminated | Phase 2 | A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ) | August 6, 2021 | November 17, 2023 |
| NCT00560846 | Terminated | N/A | Perioperative Nutrition in Upper Gastrointestinal (GI) Cancer Surgery | November 2007 | September 2012 |
| NCT04945733 | Terminated | Phase 2 | A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer | August 30, 2021 | July 3, 2023 |
| NCT02016534 | Terminated | Phase 2 | Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors | February 2014 | October 2016 |
| NCT01476553 | Terminated | N/A | Elimination of Peritoneal Tumor Cells With Extensive Peritoneal Lavage During Surgery in Patients With Gastric Cancer | February 2011 | March 2013 |
| NCT01830270 | Terminated | Phase 2 | Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer | May 2011 | July 2016 |
| NCT02512237 | Terminated | Phase 1 | A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 Expression | March 2016 | January 2017 |
| NCT04665921 | Terminated | Phase 1 | A Study of SGN-STNV in Advanced Solid Tumors | January 18, 2021 | March 1, 2024 |
| NCT00341523 | Terminated | Early Detection of Esophageal Cancer | November 1, 2016 | April 29, 2024 | |
| NCT03488446 | Unknown status | Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer（RPLNM）(GIPMCS-1701) | August 30, 2017 | March 31, 2019 | |
| NCT02289547 | Unknown status | Phase 3 | Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer | May 2015 | January 2019 |
| NCT03599895 | Unknown status | N/A | Application of 3D Printing Technique in Radical Gastrectomy With Leonardo da Vinci Robot | August 1, 2018 | March 30, 2020 |
| NCT02289183 | Unknown status | N/A | Prospective Study on Modified Delta-shaped Gastroduodenostomy in Totally Laparoscopic Surgery for Distal Gastric Cancer | January 1, 2015 | December 2023 |
| NCT02219854 | Unknown status | N/A | Single-center Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer | July 2014 | July 2020 |
| NCT03889626 | Unknown status | Phase 3 | The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer | March 22, 2019 | March 22, 2024 |
| NCT03940417 | Unknown status | Learning Curve for Robot-Assisted Gastrectomy in Gastric Cancer | October 1, 2017 | February 28, 2020 | |
| NCT02177552 | Unknown status | Phase 2 | Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma | June 2014 | November 2019 |
| NCT02136836 | Unknown status | Investigation of the Proportion of Human Epidermal Growth Factor Receptor 2 Protein Overexpression of Gastric Adenocarcinoma and Prognostic Effect of HER2, and Analysis of Practice Pattern of Herceptin Use in Stage IV Gastric Cancer | May 2014 | ||
| NCT04010006 | Unknown status | N/A | Trials Comparing of HD Versus 4K Laparoscopy for Gastric Cancer | July 15, 2019 | July 15, 2023 |
| NCT04053725 | Unknown status | Prediction of the Efficacy of ctDNA in Immunotherapy for Advanced Gastric Cancer | February 1, 2019 | November 2021 | |
| NCT02114411 | Unknown status | Gastropanel for Gastric Atrophy and Cancer Risk Assessment | January 31, 2017 | January 31, 2019 | |
| NCT00270543 | Unknown status | Phase 2 | An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer | ||
| NCT04351867 | Unknown status | Phase 3 | A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer | September 2020 | June 2024 |
| NCT02085031 | Unknown status | Phase 2 | Intracorporeal Versus Extracorporeal Roux-en-Y Esophagojejunostomy During Laparoscopic Total Gastrectomy for Gastric Cancer | April 2014 | December 2015 |
| NCT00587145 | Unknown status | Phase 2 | Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer | May 2006 | May 2009 |
| NCT00580359 | Unknown status | Phase 2 | S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer | May 2007 | June 2010 |
| NCT04522011 | Unknown status | Comparison of the Efficiency Between Intraoperative and Postoperative Hyperthermic Intraperitoneal Chemotherapy With Docetaxel Combine Oxaliplatin in Patients With Advanced Gastric Cancer | January 1, 2021 | February 28, 2023 | |
| NCT04526483 | Unknown status | N/A | L-Gastrectomy With the Intelligent Navigation 4K UHD 3D Endoscopic Imaging System | October 1, 2020 | October 1, 2022 |
| NCT01911832 | Unknown status | Phase 3 | Impact of Gastric Tube Reconstruction Widths on Quality of Life for Esophagogastric Cancers | March 2012 | February 2017 |
| NCT01609309 | Unknown status | Phase 3 | Multicenter Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer (CLASS-01) | September 2012 | December 2017 |
| NCT00384878 | Unknown status | Phase 2 | Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer | June 2006 | |
| NCT04809025 | Unknown status | Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer | May 24, 2021 | April 1, 2024 | |
| NCT00515190 | Unknown status | Phase 2 | Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma | July 2007 | August 2010 |
| NCT01185483 | Unknown status | Endoscopic Submucosal Dissection in Upper Gastrointestinal Canal With HybridKnife | November 2009 | February 2011 | |
| NCT00669370 | Unknown status | Phase 2 | Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer | June 2006 | |
| NCT02663427 | Unknown status | N/A | Serological Screening of Gastric Cancer in Wuxi Region | January 2016 | June 2018 |
| NCT02431078 | Unknown status | The Expression of ZEB1 in CTCs Associated With Metastasis and Recurrence for Gastric Cancer | June 2015 | July 2018 | |
| NCT02333721 | Unknown status | N/A | Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Middle or Upper Third Gastric Cancer | January 2015 | December 2021 |
| NCT03061058 | Unknown status | Phase 3 | Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC | April 1, 2013 | December 2019 |
| NCT03061162 | Unknown status | N/A | Pulsed Low Dose Rate Radiation Therapy for Gastric Cancer Patients With Peritoneal Metastasis | March 1, 2017 | March 1, 2022 |
| NCT02313688 | Unknown status | N/A | Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors | January 2015 | December 2023 |
| NCT02310230 | Unknown status | N/A | An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy | September 2014 | December 2016 |
| NCT03400592 | Unknown status | Phase 2 | Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric Adenocarcinoma | June 2015 | June 2018 |
| NCT03423056 | Unknown status | N/A | Efficacy and Safety of a Preoperative Aerobic Exercise Program in Patients With Gastrointestinal Cancer. | April 1, 2017 | December 31, 2019 |
| NCT02296658 | Unknown status | Phase 2 | A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer | January 2014 | December 2016 |
| NCT03447106 | Unknown status | N/A | Comparison of Open Laparoscopic and Robotic Surgery in Gastric Cancer Resection. | February 28, 2018 | December 31, 2020 |
| NCT03475615 | Unknown status | Phase 3 | A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites | March 16, 2018 | December 31, 2020 |
| NCT03482609 | Unknown status | The Effect of Postoperative Referred Pain in the Left Shoulder on Short-term Outcomes for Laparoscopic Gastrectomy | July 1, 2018 | November 1, 2021 | |
| NCT02934464 | Unknown status | Phase 3 | Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers | December 2016 | December 2021 |
| NCT02577263 | Unknown status | Impact of Adjuvant FOLFOX on Quality of Life and Sensory Neurotoxicity in Patients With Advanced Gastric Cancer | April 2015 | June 2018 | |
| NCT02949258 | Unknown status | Phase 2 | Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer | January 2017 | January 2021 |
| NCT03016026 | Unknown status | Phase 2 | Enhanced Recovery After Surgery (ERAS) on Laparoscopy-assisted Distal Gastrectomy | November 2016 | July 2018 |
| NCT00419627 | Unknown status | Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas | February 2007 | ||
| NCT00498134 | Unknown status | N/A | Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway | March 2004 | April 2013 |
| NCT05068180 | Unknown status | Phase 4 | Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients | October 5, 2021 | April 10, 2022 |
| NCT00591045 | Unknown status | Phase 2 | Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer | January 2008 | December 2012 |
| NCT00454519 | Unknown status | Phase 2 | Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis | March 2007 | |
| NCT02679495 | Unknown status | N/A | Lifestyle Intervention for Prevention of Gastric Neoplasm | March 12, 2015 | December 2023 |
| NCT02725125 | Unknown status | N/A | Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer | November 2015 | November 2019 |
| NCT05208372 | Unknown status | Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer | January 1, 2022 | January 31, 2024 | |
| NCT02777801 | Unknown status | Phase 2 | Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B Carriers | June 2015 | June 2018 |
| NCT02779608 | Unknown status | Phase 2 | The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites | January 20, 2017 | June 2018 |
| NCT02789891 | Unknown status | N/A | Randomized Controlled Trials on Laparoscopic No. 14v LNS Dissection | June 2016 | January 2024 |
| NCT02837874 | Unknown status | N/A | Comparisons Between Isoperistaltic and Antiperistaltic Gastrojejunostomy in Laparoscopic Distal Gastrectomy | March 2016 | March 2019 |
| NCT02662959 | Unknown status | Phase 2 | Irinotecan as 3rd Line Therapy in Gastric Cancer | April 2015 | |
| NCT02845986 | Unknown status | Phase 2 | Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer | September 1, 2016 | October 12, 2020 |
| NCT00420394 | Unknown status | Phase 2 | Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer | April 2007 | |
| NCT02887612 | Unknown status | ctDNA for Prediction of Relapse in Gastric Cancer | September 2016 | June 2020 | |
| NCT02930278 | Unknown status | The Effect of Preoperative Hemotologic Markers on Postoperative Long-term and Short-term Outcomes for Laparoscopic Gastrectomy | September 1, 2016 | September 2020 | |
| NCT02930291 | Unknown status | The Effect of Preoperative Inflammation-based Scores on Postoperative Morbidity and Mortality for Laparoscopic Gastrectomy | September 2016 | October 2020 | |
| NCT00620607 | Withdrawn | Phase 2 | huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas | May 2007 | September 2010 |
| NCT02919553 | Withdrawn | N/A | Modified Wet Suction Versus Capillary Techniques for EUS Guided Fine Needle Aspiration and Biopsy of Solid Lesions | January 2018 | December 2021 |
| NCT04859582 | Withdrawn | Phase 3 | Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)-China Extension | November 8, 2018 | November 29, 2024 |
| NCT01821196 | Withdrawn | N/A | Density of Neurons in the Stomach and Prognosis of Gastric Adenocarcinoma | December 2012 | February 2018 |
| NCT02594943 | Withdrawn | N/A | Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer | August 2018 | December 2019 |
- MedGen concept unique identifier (MedGen Concept name)
- CN236630
- MedGen unique identifier (MedGen Concept name)
- 880976
- MeSH unique ID (MeSH (Medical Subject Headings))
- D013274